Compound cold oral solution and preparation method thereof

A technology for oral administration and oral solution of a cold, which is applied in the field of compound cold oral solution and its preparation to achieve the effect of avoiding excessive use

Inactive Publication Date: 2017-03-08
HAINAN SANFENG PHARMA CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology describes how sensitive chemicals like methylene blue (MH) may cause problems when used for medicine due to their ability to absorb visible lights. To solve this problem, it suggests adding an antioxidant called Carbopol® instead of moxetin on top of each other's molecule. By doing this, these drugs help keep them from being oxidized too much while still maintaining its beneficial properties such as reducing side effects caused by exposure over time. Additionally, there was also suggested mixing different substances together to create another type of mixture that could improve absorption efficiency without affecting any specific property they were designed specifically against. Overall, this new method provides technical benefits to prevent damage to medication made up mostly of active ingredients.

Problems solved by technology

This patented describes various methods for producing safe and effective medicine called carmellose injection containing alpha-2 agonists like etodilators, beta blockers, calcium channel agents, etc., while also reducing their effectiveness due to excessive use over time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound cold oral solution and preparation method thereof
  • Compound cold oral solution and preparation method thereof
  • Compound cold oral solution and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] A compound cold oral solution, the formula of which is:

[0045]

[0046]

[0047] The preparation method is:

[0048] S1. Heat purified water with a capacity equivalent to 40% of the total amount of sucrose to boiling, and add sucrose and stir to dissolve;

[0049] S2. Add methylephedrine hydrochloride and chlorpheniramine maleate into the caramel, stir well, and set aside;

[0050]S3. Add the caramel solution containing methylephedrine hydrochloride and chlorpheniramine maleate to the sucrose solution in step S1, stir well, then add purified water to 7L, add acetaminophen, Potassium guaiacol sulfonate, caffeine, dextromethorphan hydrobromide, vitamin B2, add propylparaben (stir with purified water or a small amount of alcohol to dissolve before pouring in), mix and dissolve to obtain raw materials liquid;

[0051] S4. Add the raw material liquid into purified water to make the total volume 10L, stir well, keep the pH value at 5.2-5.8, heat to boiling, and keep t

Embodiment 2

[0055] A compound cold oral solution, the formula of which is:

[0056]

[0057]

[0058] The preparation method is:

[0059] S1. Heat purified water with a capacity equivalent to 40% of the total amount of sucrose to boiling, and add sucrose and stir to dissolve;

[0060] S2. Add methylephedrine hydrochloride and chlorpheniramine maleate into the caramel, stir well, and set aside;

[0061] S3. Add the caramel solution containing methylephedrine hydrochloride and chlorpheniramine maleate to the sucrose solution in step S1, stir well, then add purified water to 7L, add acetaminophen, Potassium guaiacol sulfonate and caffeine are added to propylparaben (stir with purified water or a small amount of alcohol before adding to dissolve and then pour in), mix and dissolve to obtain a raw material solution;

[0062] S4. Add the raw material liquid into purified water to make the total volume 10L, stir well, maintain the pH value at 5.2-5.8, heat to boiling, and maintain the tempe

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Login to view more

Abstract

The invention provides a compound cold oral solution and a preparation method thereof; each 10 L of the oral solution includes 5-9 g of methylephedrine hydrochloride, 0.9-1 g of chlorphenamine maleate, 100-120 g of paracetamol, 25-30 g of potassium guaiacolsulfonate, 10-15 g of caffeine, 1.2-1.5 g of propyl hydroxybenzoate, caramel, sugar, and the balance purified water, wherein the amount of the caramel is equivalent to 2.2-22 times that of methylephedrine hydrochloride, and the amount of the sucrose is equivalent to 125-167 times that of the caramel. The caramel is selected as a light shading agent, and then the sucrose is used for protecting long-term stability of the caramel, so that low concentration of methylephedrine hydrochloride and chlorpheniramine maleate can be guaranteed to be stable in the product validity period.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner HAINAN SANFENG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products